Status:
COMPLETED
redoPOEM : Failure of a First POEM
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Achalasia
Eligibility:
All Genders
18+ years
Brief Summary
observational study, measurement of efficacy in the cohort.
Detailed Description
Achalasia is a motor disorder of the esophagus with a prevalence of 1/10000. Multiple treatments have been proposed, including endoscopic dilation, botulinum toxin injection and surgery using the Hell...
Eligibility Criteria
Inclusion
- adult patient
- diagnosis of achalasia based on clinical criteria according to Eckardt score, manometry, and radiology when available.
- failure after POEM (Eckardt score \> or equal to 4 in consultation) treated with a new POEM.
- no active digestive neoplasia.
Exclusion
- Technical failure of redoPOEM
- Person not affiliated to a Social Security scheme
- Language barrier preventing fair collection of non-opposition.
Key Trial Info
Start Date :
October 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT06044155
Start Date
October 3 2023
End Date
February 28 2024
Last Update
July 10 2024
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Bordeaux
Bordeaux, France
2
Clinique des Cèdres
Cornebarrieu, France, 31700
3
CHU Dijon Bourgogne
Dijon, France, 21079
4
Centre Hospitalier Intercommunal de Toulon - La Seyne-sur-Mer
La Seyne-sur-Mer, France, 83500